Pfizer to Acquire Medivation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Barclays Downgrades Medivation (MDVN) to Equalweight
August 22, 2016 11:48 AM EDTBarclays downgraded Medivation (NASDAQ: MDVN) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $67.16 yesterday.
... More


